He is suffering huge losses in IRB Infrastructure Developers and NCC shares. Jain advises the caller to exit infra stocks and ...

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent ...

In the past 12 trading days, the market price of Biocon has appreciated by 20 per cent from a level of ₹349.65 on the BSE on April 24, 2026: Biocon Shares ...

Bengaluru-based Biocon said that its Q4 profit stood at ₹198.6. The profit was hit by an exceptional item outgo of ₹80.4 ...

At the time of filing this report, the stock of the Bangalore-based company was trading at Rs 240.10 apiece on the BSE, down ...

Biocon share price rose about 3% despite a 57% drop in Q4 FY26 net profit, as investors focused on revenue growth, margin ...

Jain also noted Emcure Pharmaceuticals is sustaining breakout levels. He recounted that the stock's initial IPO-based ...

Candidemia is a bloodstream inflection of serious proportions caused by Candida yeast, and is the fourth-most common ...

In the interview, Mazumdar-Shaw outlined her succession plan as she prepares the four-decade-old group for its next phase of growth. Her to-be successor, Claire Mazumdar, is a 37-year-old biotech ...

Biocon Biologics has been positioning itself to become a global player in biosimilar drugs. Viatris, a longtime partner to Biocon, is charting a course for its future that does not include biosimilars ...

Latest Announcements - Explore all major announcements by Natural Biocon (india) including board meetings, dividend declarations, AGM/EGM updates, bonus issues, and financial disclosures.